Stanford Peng
2016
In 2016, Stanford Peng earned a total compensation of $187.6K as Executive Vice President of Research and Development and Chief Medical Officer at Nivalis Therapeutics.
Compensation breakdown
| Option Awards | $66,408 |
|---|---|
| Salary | $121,154 |
| Total | $187,562 |
Peng received $121.2K in salary, accounting for 65% of the total pay in 2016.
Peng also received $66.4K in option awards.
Rankings
In 2016, Stanford Peng's compensation ranked 13,476th out of 14,075 executives tracked by ExecPay. In other words, Peng earned more than 4.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,476 out of 14,075 | 4th |
Division Manufacturing | 5,268 out of 5,489 | 4th |
Major group Chemicals And Allied Products | 1,841 out of 1,895 | 3rd |
Industry group Drugs | 1,494 out of 1,538 | 3rd |
Industry Pharmaceutical Preparations | 1,143 out of 1,176 | 3rd |
Source: SEC filing on April 24, 2018.
Peng's colleagues
We found four more compensation records of executives who worked with Stanford Peng at Nivalis Therapeutics in 2016.